Literature DB >> 30591746

Prevalence of lower extremities peripheral arterial disease among Egyptian ischemic patients attending cardiac rehabilitation unit.

Mohamed Waheed Basyouni1, Adel Mohamed Shabana2, Wael Mahmoud El Kilani2.   

Abstract

BACKGROUND: Atherosclerosis is progressive and diffuse pathological disorders which can simultaneously affect multiple vascular beds. Diagnosing Lower extremities peripheral arterial disease (PAD) in patients with Coronary artery disease (CAD) admitted to cardiac rehabilitation program can help to tailor exercise regimen to fit these patients, in addition, early treatment and/or intervention may help to control progression of the disease. AIM: The study is to search for the prevalence of undiagnosed PAD using ankle brachial index (ABI) in Egyptian patients with documented CAD undergoing cardiac rehabilitation program. PATIENTS AND METHODS: The study included 200 patients with documented CAD scheduled for cardiac rehabilitation in Cardiology department, Ain Shams University, with exclusion of patients with known (diagnosed) PAD. All patients underwent ABI using Doppler ultrasonography. The patients were divided into two groups; Study group with positive ABI (≤ 0.9) and Control group with negative ABI (> 0.9).
RESULTS: We found that the prevalence of undiagnosed PAD in those patients was 14.5% (29 patients). The incidence of PAD is increased in patients above 60 years (p = 0.001) and in presence of hypertension/uncontrolled systolic blood pressure (p = 0.002), Dyslipidemia (p = 0.005), or family history of ischemic heart disease (p = 0.035). PAD is associated also with impaired left ventricular systolic function and presence of segmental wall motion abnormalities at rest. Impaired eGFR increased the risk of development of PAD (p = 0.016). PAD was associated more with patients presented by multivessel lesions by coronary angiography and in presence of ischemic ECG changes.
CONCLUSION: This study shows that significant PAD is present in almost 15% of ischemic Egyptian patients. We recommend ABI to be done routinely in patients with significant CAD for exclusion or diagnosis of PAD to help in treatment and improving quality of life in addition to modification of cardiac rehabilitation program in presence of PAD according to its severity.

Entities:  

Keywords:  Egyptian; Peripheral arterial disease; Rehabilitation

Year:  2018        PMID: 30591746      PMCID: PMC6303360          DOI: 10.1016/j.ehj.2018.06.005

Source DB:  PubMed          Journal:  Egypt Heart J        ISSN: 1110-2608


Introduction

Atherosclerosis is a progressive and diffuse pathological disorder which can simultaneously affect multiple vascular beds. Postmortem studies confirmed that have the highest prevalence of atherosclerosis is found in the coronary arteries compared to other arterial beds.1, 2, 3 Lower extremities Peripheral arterial disease (PAD) is usually manifesting in concordance with systemic atherosclerotic process including coronary artery disease (CAD).1, 2 Diagnosing PAD in patients with CAD can help to change the exercise regimen prescribed to these patients in cardiac rehabilitation program to fit both pathologies, in addition to early treatment and/or intervention if required.4, 5, 6, 7, 8, 9, 10 ABI is the ratio of the systolic blood pressure (SBP) measured at the ankle to that measured at the brachial artery. This index is not only used for the noninvasive diagnosis of PAD12, 13, but it also has a prognostic value for cardiovascular events and functional impairment, even in the absence of symptoms of PAD.14, 15, 16, 17, 18, 19, 20, 21 For diagnosis of significant lower extremity PAD (more than 50% stenosis), ABI was found to have a sensitivity of more than 90% and a specificity of more than 95% in several studies, when compared to angiography.22, 23, 24, 25, 26, 27 To the best of our knowledge, there are no published data assessing the prevalence of PAD in cardiac ischemic patients in Egypt. The aim of this study is to investigate for prevalence of undiagnosed lower extremities PAD using ABI among Egyptian patients with documented CAD undergoing cardiac rehabilitation program.

Subjects and methods

This study included (200) patients presented to (Ain Shams University -Aldemerdash- Hospital), cardiac rehabilitation clinic from January 2015 to November 2015, who had documented CAD and underwent percutaneous coronary intervention (PCI). Patients with previously diagnosed PAD and those refusing to sign the consent were excluded. In addition to history, clinical examination, laboratory tests and echocardiography, the Ankle brachial index was measured using a portable vascular Doppler scanning (Nicolet vascular Elite, VIASYS healthcare, USA) and aneroid sphygmomanometer with appropriate cuff inflators for brachial circumference as previously described in literature11, 23, 28 ABI was considered as positive if it is ≤0.9.

Statistical analysis

Categorical variables will be expressed as number (%) and continuous variables will be expressed as mean ± SD. The independent sample t-test and ANOVA will be used to compare the mean values of different groups. For all tests, p value <0.05 will be considered statistically significant. All the analyses will be performed with commercially available software (SPSS version 20.0; SPSS, Inc., Chicago, IL, USA).

Results

This study assessed 200 patients who have a documented CAD and admitted to cardiac rehabilitation program, for detection of undiagnosed PAD using ABI. In this study, we divided the patients into two groups according to the results of ABI measurements as follows: Group I with ABI ≤ 0.9 (29 patients) and group II (control group) with ABI > 0.9 (171 patients). The age of our studied patients ranged from 37 to 80 years with mean age of 54.73 ± 9.163 and most of our study population were males (162 patients). Our data showed that gender did not have statistically significant correlation with presence of PAD. On the contrary, prevalence of PAD was highest in those above age of 60 years and lowest below 40 years old. Table 1 shows characteristics of the study population.
Table 1

Shows main characteristics of the study population, comparing group I and group II.

PAD: peripheral arterial disease, DM: diabetes mellitus, HTN: hypertension, DLP: dyslipidemia, SWMA: segmental wall motion abnormalities (by echocardiography), LV EF: left ventricular ejection fraction (by echocardiography), CAD: coronary artery disease, STEMI: ST segment elevation myocardial infarction, NSTEMI: non-ST segment elevation myocardial infarction, UA: unstable angina, MVD: multivessel disease, LAD: left anterior descending artery, RCA: Right coronary artery, Lcx: Left circumflex artery, PDA: posterior descending artery, TG: Triglycerides, eGFR: estimated glomerular filtration rate, LDL: Low density lipoprotein, HDL: High density lipoprotein

Shows main characteristics of the study population, comparing group I and group II. PAD: peripheral arterial disease, DM: diabetes mellitus, HTN: hypertension, DLP: dyslipidemia, SWMA: segmental wall motion abnormalities (by echocardiography), LV EF: left ventricular ejection fraction (by echocardiography), CAD: coronary artery disease, STEMI: ST segment elevation myocardial infarction, NSTEMI: non-ST segment elevation myocardial infarction, UA: unstable angina, MVD: multivessel disease, LAD: left anterior descending artery, RCA: Right coronary artery, Lcx: Left circumflex artery, PDA: posterior descending artery, TG: Triglycerides, eGFR: estimated glomerular filtration rate, LDL: Low density lipoprotein, HDL: High density lipoprotein Among the conventional risk factors for atherosclerotic vascular disease, only the presence of hypertension and dyslipidemia, were found to carry statistically significant difference between both groups. In addition, there was statistically significant correlation between PAD and presence of ischemic ECG changes, Low left ventricular ejection fraction and the presence of wall motion abnormalities in echocardiography. Moreover, there was statistically significant correlation between the presentation of ST segment elevation myocardial infarction (STEMI) and incidence of PAD. The incidence of PAD was also increased among patients with Left Anterior Descending artery (LAD) lesions and multivessel disease but did not reach statistical significance. Fig. 1 summarizes the relation between presence of PAD and the coronary vessels affected.
Fig. 1

Differences between study and control groups regarding presentation and details of coronary angiography. STEMI: ST segment elevation myocardial infarction, LAD: left anterior descending artery, RCA: right coronary artery, Lcx: left circumflex artery, PDA: posterior descending artery.

Differences between study and control groups regarding presentation and details of coronary angiography. STEMI: ST segment elevation myocardial infarction, LAD: left anterior descending artery, RCA: right coronary artery, Lcx: left circumflex artery, PDA: posterior descending artery.

Discussion

Our study assessed 200 patients with documented CAD who underwent PCI, and joined cardiac rehabilitation program. ABI was used for detection of undiagnosed PAD, being an inexpensive, simple, and reproducible test that can be easily performed in the office or at the bedside. In our study, the prevalence of undiagnosed PAD in patients with CAD was 14.5%. These results were concordant with Dieter et al., who assessed a total of 100 patients (66 men and 34 women) and found a 19% prevalence of undiagnosed PAD. However other studies found a prevalence as high as 26.6%. The difference between results may be due to the variation in number of studied patients and, different studied populations as well as prevalence of risk factors in studied patients. Our study demonstrated increased incidence of PAD in patients over 60 years, that was previously shown in Egyptian patients where the lowest ABI values were present in patients above the age of 70 years in study group (ABI ≤ 0.9) with mean ABI of 0.708 (p < 0.001). Similar data were obtained in other studies. Regarding the conventional risk factors of atherosclerosis, our study results demonstrated increased prevalence of PAD in presence of history of hypertension (89.7%) or dyslipidemia (82.2%). These results were concordant with previous studies.29, 32 Smoking and diabetes mellitus are well known risk factors for PAD as well as CAD. Data derived from several observational studies indicate a twofold to fivefold increased risk of PAD in smokers.33, 34, 35, 36, 37, 38, 39, 40 Similarly, the risk of development of PAD increases threefold to fourfold in patients with DM.34, 37, 38, 41, 42 However, our study did not show significant correlation between smoking or DM and diagnosis of PAD. This could be explained by the observation that the prevalence of each of the two risk factors was high in both groups; Our patients are already atherosclerotic with documented CAD. Analysis of our data showed that almost half of subjects in each group were diabetic and more than two thirds were smokers in each group. In the current study, intermittent claudication was present in 41.4% (12 patients) of patients with positive ABI and in only 19.9% (34 patients) of those with negative ABI (P = 0.011), while ischemic changes in lower limbs was found in only one patient of the study who belongs to the study group. This could justify the importance of screening for PAD by adequate history taking, clinical examination and ABI. In our study, the highest prevalence of PAD was present in patients with LAD lesions, followed by RCA lesions then multivessel disease. In addition, STEMI presentation was more associated with PAD than other presentations of ACS. These results were in concordance with Cavalcanti et al., who studied the association between ABI and coronary lesions assessed by coronary angiography, this study included 163 patients with a clinical diagnosis of stable angina. They found that LAD lesions were present in 57.6% of patients and RCA lesions occurred in 47.2% of patients and LCX lesions in 38% of patients. On multivariate Poisson regression, an ABI < 0.9 was only an independent predictor of LAD stenosis (P < 0.001). High prevalence of PAD among patients with multivessel CAD was also found in previous studies. Echocardiographic findings have been found to be a clue for PAD in our study; PAD was present in 18.4% of patients with SWMA and not present at all in patients without SWMA. Tsao and colleagues studied the relation between presence of left ventricular SWMA (by MRI) and prevalence of PAD using ABI. Among 1726 patients, they found that lower ABI was associated with the presence of SWMA; (38% of patients with SWMA and in only 8% of patients without SWMA (P < 0.001)]. This high prevalence compared to the present study may be attributed to the smaller number of studied patients, different patient inclusion criteria and different methods of assessment of SWMA. In our study, lower ABI was also associated with decreased eGFR (P = 0.016). The mean eGFR value was 73.48 in study group and 81.99 in control group (p = 0.032). Such finding is concordant with Qing and Hongbo,, who found that among 612 geriatric patients 24% had positive ABI, and ABI values were significantly lower in patients with decreased eGFR compared to those with normal eGFR (p = 0.000). The Chinese Ankle Brachial Index Cohort found that the prevalence of PAD in patients with and without CKD was 41.9% and 22.3%, respectively (p < 0.001) and the combined CKD and PAD patients had the highest risk for all-cause and CVD mortality. In conclusion, ABI can be used routinely in patients with significant CAD, being simple, inexpensive, non invasive and available method for exclusion or diagnosis of PAD if present as early diagnosis will help in treatment and improving quality of life in addition to modification of cardiac rehabilitation program in presence of PAD according to its severity.

Limitations

The study included only 200 patients who have documented CAD and Patients with documented PAD were excluded from the study. Data about peripheral angiography (gold standard for diagnosis of PAD) in patients with + ve ABI was not followed in the study.

Conflict of interest

None.
  46 in total

Review 1.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

Authors:  J A Dormandy; R B Rutherford
Journal:  J Vasc Surg       Date:  2000-01       Impact factor: 4.268

Review 2.  Exercise training for claudication.

Authors:  Kerry J Stewart; William R Hiatt; Judith G Regensteiner; Alan T Hirsch
Journal:  N Engl J Med       Date:  2002-12-12       Impact factor: 91.245

Review 3.  Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.

Authors:  B Girolami; E Bernardi; M H Prins; J W Ten Cate; R Hettiarachchi; P Prandoni; A Girolami; H R Büller
Journal:  Arch Intern Med       Date:  1999-02-22

4.  Exercise training in intermittent claudication.

Authors:  R Gibellini; M Fanello; A F Bardile; M Salerno; T Aloi
Journal:  Int Angiol       Date:  2000-03       Impact factor: 2.789

5.  Peripheral arterial disease detection, awareness, and treatment in primary care.

Authors:  A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

6.  Effects of long-term exercise rehabilitation on claudication distances in patients with peripheral arterial disease: a randomized controlled trial.

Authors:  Andrew W Gardner; Leslie I Katzel; John D Sorkin; Andrew P Goldberg
Journal:  J Cardiopulm Rehabil       Date:  2002 May-Jun       Impact factor: 2.081

7.  Morphometric and immunohistochemical characterization of the intimal layer throughout the arterial system of elderly humans.

Authors:  Aryan Vink; Arjan H Schoneveld; Marieke Poppen; Dominique P V de Kleijn; Cornelius Borst; Gerard Pasterkamp
Journal:  J Anat       Date:  2002-01       Impact factor: 2.610

Review 8.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

9.  Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease.

Authors:  Robert S Dieter; Jon Tomasson; Thorbjorn Gudjonsson; Roger L Brown; Mark Vitcenda; Jean Einerson; Patrick E McBride
Journal:  Vasc Med       Date:  2003-11       Impact factor: 3.239

10.  High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.

Authors:  Curt Diehm; Alexander Schuster; Jens R Allenberg; Harald Darius; Roman Haberl; Stefan Lange; David Pittrow; Berndt von Stritzky; Gerhart Tepohl; Hans-Joachim Trampisch
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.